New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention

Background. Coronary heart disease is the leading cause of death in the Russian Federation, causing social and economic damage to the state. Previously published studies showed the association of rs1800470 polymorphism of the gene of the transforming growth factor-β1 (TGF-β1) with the risk of develo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: D. A. Brusentsov, P. A. Shesternya
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/a8dad3d198634f94aed4e9be0a33a108
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8dad3d198634f94aed4e9be0a33a108
record_format dspace
spelling oai:doaj.org-article:a8dad3d198634f94aed4e9be0a33a1082021-11-23T06:14:44ZNew Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention2541-94202587-959610.29413/ABS.2020-5.4.7https://doaj.org/article/a8dad3d198634f94aed4e9be0a33a1082020-09-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/2392https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596Background. Coronary heart disease is the leading cause of death in the Russian Federation, causing social and economic damage to the state. Previously published studies showed the association of rs1800470 polymorphism of the gene of the transforming growth factor-β1 (TGF-β1) with the risk of developing coronary artery disease due to more severe atherosclerotic lesions of the coronary arteries. Aim of the research. To study the association of single-nucleotide polymorphism rs1800470 of the TGF-β1 gene with the rate of progression of atherosclerotic coronary artery lesion. Material and methods. The study included 89 men with myocardial infarction, a Caucasian race under the age of 65 years (51 ± 7.9). Genomic DNA was isolated from venous blood by the phenol-chloroform method. The rs1800470 polymorphism of the TGF-β1 gene was tested using real-time polymerase chain reaction (PCR) (TaqMan probes, AB 7900HT). Assessment of the severity of coronary lesion was carried out initially according to the standard polyprojection coronary angiography protocol with the Gensini score calculated, as well as in dynamics after 40.7 ± 29.7 months (from 5 to 103 months). Results. Carrier of the rs1800470 allele A of the TGF-β1 gene is an independent risk factor for coronary heart disease and is associated with a more aggressive course of coronary atherosclerosis in men: a 20 % worsening of the Gensini score was observed after 7 months (p = 0.013), and by 30 % after 5 months (p = 0.003) from the initial coronary angiography. In addition, the homozygous genotype AA rs1800470 of the TGF-β1 gene is associated with the development of late stent restenoses in this group of patients after 12 months of observation (p = 0.002). Conclusion. Identification of carriers of the rs1800470 allele A of the TGF-β1 gene can help identify patients at risk for more rapid progression of coronary artery atherosclerosis in order to conduct angiographic control in the early period – 6 months from the initial percutaneous coronary intervention.D. A. BrusentsovP. A. ShesternyaScientific Сentre for Family Health and Human Reproduction Problemsarticlesingle nucleotide polymorphismgeneticsmyocardial infarctiongene of the transforming growth factor beta-1atherosclerosiscoronary angiographyScienceQRUActa Biomedica Scientifica, Vol 5, Iss 4, Pp 51-59 (2020)
institution DOAJ
collection DOAJ
language RU
topic single nucleotide polymorphism
genetics
myocardial infarction
gene of the transforming growth factor beta-1
atherosclerosis
coronary angiography
Science
Q
spellingShingle single nucleotide polymorphism
genetics
myocardial infarction
gene of the transforming growth factor beta-1
atherosclerosis
coronary angiography
Science
Q
D. A. Brusentsov
P. A. Shesternya
New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention
description Background. Coronary heart disease is the leading cause of death in the Russian Federation, causing social and economic damage to the state. Previously published studies showed the association of rs1800470 polymorphism of the gene of the transforming growth factor-β1 (TGF-β1) with the risk of developing coronary artery disease due to more severe atherosclerotic lesions of the coronary arteries. Aim of the research. To study the association of single-nucleotide polymorphism rs1800470 of the TGF-β1 gene with the rate of progression of atherosclerotic coronary artery lesion. Material and methods. The study included 89 men with myocardial infarction, a Caucasian race under the age of 65 years (51 ± 7.9). Genomic DNA was isolated from venous blood by the phenol-chloroform method. The rs1800470 polymorphism of the TGF-β1 gene was tested using real-time polymerase chain reaction (PCR) (TaqMan probes, AB 7900HT). Assessment of the severity of coronary lesion was carried out initially according to the standard polyprojection coronary angiography protocol with the Gensini score calculated, as well as in dynamics after 40.7 ± 29.7 months (from 5 to 103 months). Results. Carrier of the rs1800470 allele A of the TGF-β1 gene is an independent risk factor for coronary heart disease and is associated with a more aggressive course of coronary atherosclerosis in men: a 20 % worsening of the Gensini score was observed after 7 months (p = 0.013), and by 30 % after 5 months (p = 0.003) from the initial coronary angiography. In addition, the homozygous genotype AA rs1800470 of the TGF-β1 gene is associated with the development of late stent restenoses in this group of patients after 12 months of observation (p = 0.002). Conclusion. Identification of carriers of the rs1800470 allele A of the TGF-β1 gene can help identify patients at risk for more rapid progression of coronary artery atherosclerosis in order to conduct angiographic control in the early period – 6 months from the initial percutaneous coronary intervention.
format article
author D. A. Brusentsov
P. A. Shesternya
author_facet D. A. Brusentsov
P. A. Shesternya
author_sort D. A. Brusentsov
title New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention
title_short New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention
title_full New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention
title_fullStr New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention
title_full_unstemmed New Opportunities for Determining the Terms of Carrying out the Control Coronarangiography after Percutaneous Coronary Intervention
title_sort new opportunities for determining the terms of carrying out the control coronarangiography after percutaneous coronary intervention
publisher Scientific Сentre for Family Health and Human Reproduction Problems
publishDate 2020
url https://doaj.org/article/a8dad3d198634f94aed4e9be0a33a108
work_keys_str_mv AT dabrusentsov newopportunitiesfordeterminingthetermsofcarryingoutthecontrolcoronarangiographyafterpercutaneouscoronaryintervention
AT pashesternya newopportunitiesfordeterminingthetermsofcarryingoutthecontrolcoronarangiographyafterpercutaneouscoronaryintervention
_version_ 1718416898708733952